XML 234 R63.htm IDEA: XBRL DOCUMENT v3.4.0.3
Significant equity transactions, restructuring transactions, mergers and acquisitions and equity investments- Alibaba Health (Details)
HKD in Millions, $ in Millions
1 Months Ended 12 Months Ended
Jul. 31, 2015
CNY (¥)
Apr. 30, 2014
HKD
Apr. 30, 2014
CNY (¥)
Mar. 31, 2016
CNY (¥)
Mar. 31, 2016
USD ($)
Mar. 31, 2016
CNY (¥)
Jul. 31, 2015
HKD
Jul. 31, 2015
CNY (¥)
Mar. 31, 2015
CNY (¥)
Mar. 31, 2014
CNY (¥)
The allocation of the equity value at the date of the deemed acquisition                    
Goodwill         $ 12,662 ¥ 81,645,000,000     ¥ 41,933,000,000 ¥ 11,793,000,000
User base and customer relationships | Maximum                    
The equity value comprised of:                    
Estimated amortization periods       6 years            
Trade names, trademarks and domain names | Maximum                    
The equity value comprised of:                    
Estimated amortization periods       12 years            
Developed technology and patents | Maximum                    
The equity value comprised of:                    
Estimated amortization periods       5 years            
Yunfeng Capital                    
Acquisition                    
Executive chairman's percentage interest in related parties   40.00% 40.00%              
Alibaba Health                    
Acquisition                    
Equity interest held (as a percentage)             54.00% 54.00%    
Equity value             HKD 64,319 ¥ 50,723,000,000    
Gain recognized in relation to the revaluation of previously held equity interest relating to obtaining control       ¥ 18,603,000,000            
The allocation of the equity value at the date of the deemed acquisition                    
Net assets acquired               1,290,000,000    
Goodwill               49,320,000,000    
Deferred tax assets               19,000,000    
Deferred tax liabilities               (19,000,000)    
Total             HKD 64,319 50,723,000,000    
The equity value comprised of:                    
- fair value of previously held equity interests ¥ 19,264,000,000                  
- fair value of noncontrolling interests 31,459,000,000                  
Total ¥ 50,723,000,000                  
Weighted average amortization period 2 years 7 months 6 days                  
Alibaba Health | Maximum                    
The equity value comprised of:                    
Estimated amortization periods 3 years                  
Alibaba Health | User base and customer relationships                    
The allocation of the equity value at the date of the deemed acquisition                    
Amortizable intangible assets               8,000,000    
Alibaba Health | Trade names, trademarks and domain names                    
The allocation of the equity value at the date of the deemed acquisition                    
Amortizable intangible assets               35,000,000    
Alibaba Health | Developed technology and patents                    
The allocation of the equity value at the date of the deemed acquisition                    
Amortizable intangible assets               ¥ 70,000,000    
Special purpose entity | Ordinary Shares                    
Acquisition                    
Equity interest (as a percent)   70.00% 70.00%              
Alibaba Health                    
Acquisition                    
Equity interest held in subsidiary (as a percentage)             38.00% 38.00%    
Alibaba Health | Ordinary Shares                    
Acquisition                    
Equity interest (as a percent)   38.00% 38.00%              
Purchase consideration, equity method   HKD 932 ¥ 741,000,000              
Alibaba Health | Yunfeng Capital                    
Acquisition                    
Consideration paid to related party for giving up its voting rights with respect to its indirect interest in investee ¥ 0                  
Company and Yunfeng Capital | Alibaba Health | Ordinary Shares                    
Acquisition                    
Equity interest (as a percent)   54.00% 54.00%              
Yunfeng Capital | Special purpose entity | Ordinary Shares                    
Acquisition                    
Equity interest (as a percent)   30.00% 30.00%